- Home
- ABOS vs SRBK Comparison
ABOS vs SRBK Comparison
Compare ABOS & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.85
Company Overview
Basic Information| Metric | ABOS | SRBK |
|---|---|---|
| Founded | 1996 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.5M | 123.7M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABOS | SRBK |
|---|---|---|
| Price | $1.85 | $16.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.67 | N/A |
| AVG Volume (30 Days) | ★ 220.8K | 36.7K |
| Earning Date | 11-12-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 1.21% |
| EPS Growth | N/A | ★ 374.69 |
| EPS | N/A | ★ 0.54 |
| Revenue | N/A | ★ $31,130,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $30.59 |
| Revenue Growth | N/A | ★ 0.85 |
| 52 Week Low | $0.86 | $11.36 |
| 52 Week High | $2.46 | $17.11 |
Technical Indicators
Market Signals| Indicator | ABOS | SRBK |
|---|---|---|
| Relative Strength Index (RSI) | 45.49 | 65.03 |
| Support Level | $1.67 | $16.35 |
| Resistance Level | $1.99 | $16.92 |
| Average True Range (ATR) | 0.14 | 0.41 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 38.30 | 92.93 |
Price Performance
Historical Comparison ABOS
SRBK
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About SRBK SR Bancorp Inc.
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.